Geode Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-466,863
| Closed | -$952K | – | 5060 |
|
|
2021
Q3 | $952K | Sell |
466,863
-16
| -0% | -$37 | ﹤0.01% | 3707 |
|
|
2021
Q2 | $1.39M | Sell |
466,879
-256,190
| -35% | -$676K | ﹤0.01% | 3439 |
|
|
2021
Q1 | $2M | Buy |
723,069
+144,645
| +25% | +$436K | ﹤0.01% | 3253 |
|
|
2020
Q4 | $1.41M | Buy |
578,424
+3,644
| +0.6% | +$8.78K | ﹤0.01% | 3254 |
|
|
2020
Q3 | $1.21M | Buy |
574,780
+38,080
| +7% | +$128K | ﹤0.01% | 3132 |
|
|
2020
Q2 | $2.03M | Buy |
536,700
+4,606
| +0.9% | +$13.8K | ﹤0.01% | 2829 |
|
|
2020
Q1 | $1M | Buy |
532,094
+135,490
| +34% | +$352K | ﹤0.01% | 3019 |
|
|
2019
Q4 | $828K | Buy |
396,604
+42,020
| +12% | +$80.6K | ﹤0.01% | 3339 |
|
|
2019
Q3 | $847K | Buy |
354,584
+139,294
| +65% | +$374K | ﹤0.01% | 3283 |
|
|
2019
Q2 | $673K | Buy |
215,290
+177,823
| +475% | +$653K | ﹤0.01% | 3358 |
|
|
2019
Q1 | $186K | Hold |
37,467
| – | – | ﹤0.01% | 3759 |
|
|
2018
Q4 | $167K | Hold |
37,467
| – | – | ﹤0.01% | 3725 |
|
|
2018
Q3 | $181K | Sell |
37,467
-161
| -0.4% | -$824 | ﹤0.01% | 3791 |
|
|
2018
Q2 | $225K | Sell |
37,628
-62,897
| -63% | -$460K | ﹤0.01% | 3687 |
|
|
2018
Q1 | $889K | Buy |
100,525
+21,432
| +27% | +$160K | ﹤0.01% | 3176 |
|
|
2017
Q4 | $573K | Buy |
79,093
+13,554
| +21% | +$84.7K | ﹤0.01% | 3305 |
|
|
2017
Q3 | $452K | Buy |
65,539
+4,476
| +7% | +$30.9K | ﹤0.01% | 3396 |
|
|
2017
Q2 | $436K | Buy |
61,063
+46,052
| +307% | +$213K | ﹤0.01% | 3399 |
|
|
2017
Q1 | $71K | Buy |
+15,011
| New | +$46K | ﹤0.01% | 3890 |
|
Geode Capital Management's SBBP Position: Q4 2021 in Review
Geode Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 466,863 shares — an estimated $952K sold.
Geode Capital Management first reported a position in SBBP in Q1 2017 and held it in 19 quarters. The position peaked at $2.03M in Q2 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- Geode Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- Geode Capital Management sold 466,863 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $952K.
- Geode Capital Management first reported a position in Strongbridge Biopharma plc. in Q1 2017 and held it in 19 quarters.
- Geode Capital Management's Strongbridge Biopharma plc. position peaked at $2.03M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.